Home > Cashflow Statement > GLAND PHARMA

GLAND PHARMA
Cashflow Statement

GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Cashflow Statement History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Profit Before Tax₹1,133 Cr₹1,055 Cr₹1,619 Cr₹1,335 Cr₹993 Cr
Adjustment ₹224 Cr₹38 Cr₹-28 Cr₹17 Cr₹32 Cr
Changes In working Capital ₹-53 Cr₹-418 Cr₹-393 Cr₹-436 Cr₹-80 Cr
Cash Flow after changes in Working Capital ₹1,303 Cr₹675 Cr₹1,197 Cr₹916 Cr₹945 Cr
Cash Flow from Operating Activities ₹997 Cr₹364 Cr₹791 Cr₹605 Cr₹701 Cr
Cash Flow from Investing Activities ₹-1,757 Cr₹1,208 Cr₹-1,003 Cr₹-1,524 Cr₹-766 Cr
Cash Flow from Financing Activities ₹-799 Cr₹15 Cr₹35 Cr₹1,238 Cr₹-6.87 Cr
Net Cash Inflow / Outflow ₹-1,560 Cr₹1,587 Cr₹-177 Cr₹319 Cr₹-72 Cr
Opening Cash & Cash Equivalents ₹1,909 Cr₹319 Cr₹492 Cr₹169 Cr₹236 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations ₹7.72 Cr₹3.00 Cr₹3.31 Cr₹3.58 Cr₹5.11 Cr
Closing Cash & Cash Equivalent ₹357 Cr₹1,909 Cr₹319 Cr₹492 Cr₹169 Cr

Compare Cashflow Statement of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹30,084.2 Cr 0.9% 0.2% -2.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,838.0 Cr 1% 0.7% 47.3% Stock Analytics
DIVIS LABORATORIES ₹156,107.0 Cr -1.1% -5.8% 61.7% Stock Analytics
CIPLA ₹120,270.0 Cr 0.3% -1.8% 19.6% Stock Analytics
DR REDDYS LABORATORIES ₹113,077.0 Cr 6% 11.8% 20.3% Stock Analytics
ZYDUS LIFESCIENCES ₹96,553.2 Cr -1.5% -0.1% 47% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

0.9%

0.2%

-2.5%

SENSEX

-2.1%

-2%

11.3%


You may also like the below Video Courses